Eli Lilly
LLY · NYSE · Healthcare
SEC EDGARFilings checked 15 Sept 2026, 22:20 UTCFinancials checked 15 Sept 2026, 22:20 UTC
Annual reporting period: 2025-01-01 — 2025-12-31 · USD
Annual revenue$65.18BYear over year +44.7%
Annual net income$20.64BConsolidated net income
Annual operating income—Standard fact unavailable
Operating margin—Operating income / revenue
Revenue over time
ANNUALEach bar represents annual revenue for the fiscal year ending on the stated date. Compact amounts are rounded; exact values and filings are listed below.
Company & data
ELI LILLY & Co
Pharmaceutical Preparations
Market: United States
Currency: USD
CIK: 59478
A recent filing date is not a new financial period. Annual figures may remain unchanged until the next annual report, even when new current reports are filed.
How this data is calculated →Annual financials & sources
CONSOLIDATED| FISCAL END | REVENUE | NET INCOME | OPERATING INCOME | SOURCE |
|---|---|---|---|---|
| 2025-12-31 | $65.18B65,179,000,000 USD | $20.64B20,640,000,000 USD | —— | Filing ↗ |
| 2024-12-31 | $45.04B45,043,000,000 USD | $10.59B10,590,000,000 USD | —— | Filing ↗ |
| 2023-12-31 | $34.12B34,124,000,000 USD | $5.24B5,240,000,000 USD | —— | Filing ↗ |
| 2022-12-31 | $28.54B28,541,400,000 USD | $6.24B6,244,800,000 USD | —— | Filing ↗ |
Amounts use currency-specific compact units. Exact amounts appear below each rounded value. An em dash means unavailable, not zero.